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Introduction
Cardiovascular disease (CVD) represents the result of underlying
genetic predisposition and lifetime exposure to multiple environmen-
tal factors. The past century has seen a revolution in our understand-
ing of the importance of modifiable risk factors such as diet, exercise,
and smoking. Exposure to environmental pollutants, be it in the air,
water, or physical environment, is increasingly recognized as a silent,
yet important determinant of CVD.1 The quote ‘genetics loads the
gun but the environment pulls the trigger’, put forward by G.A. Bray
and F. Collins, exemplifies the complex relationship between human
disease and the environment. The cardiovascular system is highly vul-
nerable to a variety of environmental insults, including tobacco
smoke, solvents, pesticides, and other inhaled or ingested pollutants,
as well as extremes in noise and temperature. While our understand-
ing of multiple environmental factors continues to evolve, it is esti-
mated that environmental air pollution and noise pollution alone may
contribute to a substantial burden attributable to environmental fac-
tors as we currently understand them. It is important to note that
noise and air pollution can have many of the same sources such as
heavy industry, road and aircraft vehicles. In a recent in-depth report,
the European Commission acknowledged that the societal costs for
the combination noise and air pollution are nearly 1 trillion
Euros, while the costs for alcohol and smoking are considerably less
(50–120 and 540 billion Euro, respectively, see https://ec.europa.
eu/environment/integration/research/newsalert/pdf/air_noise_pol
lution_socioeconomic_status_links_IR13_en.pdf).
The World Health Organization (WHO) calculates that 12.6 mil-
lion premature deaths per year are attributable to unhealthy environ-
ments, 8.2 million of which are due to non-communicable disease,
with CVD (including stroke) being the largest contributor, accounting
for nearly 5 million of these deaths.2 Among all environmental pollu-
tants, poor air quality is the most important risk factor, and ambient
air pollution due to particulate matter <2.5mm (PM2.5) exposure
ranks 5th among all global risk factors in 2015, leading to 4.2 million
deaths annually as estimated by the Global Burden of Disease study.3
Nine out of 10 people worldwide are exposed to ambient air pollu-
tant levels above WHO guidelines (>10mg/m).3,4 Using a novel
exposure-response hazard function (global estimate of exposure
mortality model) to estimate global mortality attributable to air pollu-
tion, Burnett et al.5 and Lelieveld et al.6 found that around 9 million
global premature deaths (790 000 excess deaths in Europe alone)
were attributable to air pollution,7 numbers that are well comparable
to that of smoking.6 These figures are substantially higher than those
estimated by the WHO and Global Burden of Disease study.2,3
Ambient noise is the other omnipresent exposure with emerging
data suggesting a large attributable burden of disability to this factor
in many urban environments. In Western Europe, it is estimated that
around 1.6 million healthy life years are lost every year due to noise.
It is estimated that a large part of the European population is exposed
to noise originating from road traffic at levels exceeding 55 decibels
[dB(A), A-weighted decibel scale adapted to the human hearing fre-
quencies]; 20% exposed to levels exceeding 65 dB(A) during the day-
time; and 30% of the population is exposed to levels exceeding
55 dB(A) (see https://www.eea.europa.eu/publications/environmen
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tal-noise-in-europe). In this review, we will focus on the cardiovascu-
lar effects of ambient air pollution and noise pollution as prototypical
environmental factors that provide important lessons to facilitate
understanding of the outsize effects of the environment on suscepti-
bility to CVD. The pathophysiology, epidemiology, mitigation meas-
ures, and future challenges for these two common yet pervasive
environmental factors are discussed in detail.
In many parts of the world, a substantial portion of the urban
population is exposed to road traffic noise at levels exceeding
55 dB(A).8 In cities in Asia, the proportion of the population reaching
Lden levels (day–evening–night level, i.e. the average sound pressure
level measured over a 24 h period with adjustment for more detri-
mental health effects of nocturnal noise) of 60–64 dB is very high.9
In contrast to the relatively straightforward classification of noise, air
pollution is intrinsically complex and defy easy classification. From a
regulatory perspective, ‘criteria’ air pollutants allow health-based
and/or environmentally based guidelines for setting permissible lev-
els.10 These include carbon monoxide, lead, nitrogen oxides, ground-
level ozone, particle pollution (often referred to as PM), and sulphur
oxides. Particulate matter is categorized based on its aerodynamic
diameter: <_10lm [thoracic particles (PM10)], <_2.5 lm [fine particles
(PM2.5)], <_0.1 lm [ultrafine particles (UFP)], and between 2.5 and
10lm [coarse particles (PM2.5–10)]. Although ‘criteria’ pollutants are
regulated individually, it is anticipated that the effects of air pollution
are driven by the complex interaction of particulate and gaseous
components in mixtures and that smaller particles (e.g. UFP) are
more detrimental then larger ones.
There is substantial spatial and temporal variation of both noise
and air pollution. Traffic-related pollutants and noise often peaking
during the late morning and evening rush hours. Gradients for both
noise and air pollutants are also dependent upon meteorological con-
ditions, including diurnal changes in vertical mixing height, wind speed,
and temperature. In the case of noise, the gradients are substantial as
the intensity of noise decreases exponentially with the distance from
its source. The gradients for air pollution from their source may also
differ depending upon the pollutant. Traffic factors, such as the speed,
traffic load, etc., may also differentially affect noise and traffic-related
air pollution. During traffic congestion, when traffic is at standstill or
at lower engine speeds, noise levels may be lower, but emissions may
be dramatically higher, contributing to marked surges in traffic-
related air pollutants. In contrast, when traffic is moving well, noise
levels may be higher, but emissions may be lower. Environmental
factors such as road conditions, noise barriers, and surrounding
buildings are well known to influence traffic noise but may not influ-
ence air pollution substantially.
The highly associated nature of traffic noise and air pollution makes
it challenging to isolate their independent effects on cardiovascular
events in epidemiological studies. A few studies have attempted to
assess the independent contribution of noise from air pollution
and vice versa. The results are, however, somewhat variable, with
some studies demonstrating an independent effect of noise and/or
air pollution on cardiovascular morbidity and mortality, while
others find marked attenuation of effects after adjusting for the
other. Whether noise and air pollution have differing, additive,
synergistic, and/or confounding effects upon cardiovascular health
is still incompletely understood. Also of great importance in all air
pollution and noise exposure studies is the co-linearity of these
risk factors to other confounders (e.g. lower socio-economic
status, psychosocial stressors, other poorly understood environ-
mental variables and adverse lifestyle factors) that often go hand-
in-hand with pollutants.
Pathophysiology and
epidemiology of noise and
cardiovascular disease
Epidemiology
During the last decade, a number of epidemiological studies have
investigated effects of transportation noise on risk for CVD. In 2018,
a systematic review by WHO found that there was substantial
evidence to conclude that road traffic noise increases the risk for
ischaemic heart disease, with an 8% higher risk per 10 dB higher
noise.11 For stroke, the evidence was ranked as moderate, with only
one study on incidence and four on mortality.11 Subsequently, large
population-based studies from Frankfurt, London, and Switzerland
found road traffic noise to increase stroke incidence and/or mortality,
especially ischaemic strokes,12–14 whereas smaller cohort studies
indicated no association.15 Recently, road traffic noise has been found
to increase the risk for other major CVD not evaluated by WHO,
most importantly heart failure and atrial fibrillation.14,16 Aircraft noise
has also been associated with higher CVD incidence and mortal-
ity,14,17 but due to a limited number of studies, the evidence is still
rated low to moderate.18
Epidemiological studies have linked transportation noise with a
number of major cardiovascular risk factors, most consistently obes-
ity and diabetes.19,20 Also, many studies investigated effects of noise
on hypertension, and although a meta-analysis of 26 studies found
that road traffic noise was associated with higher prevalence of
hypertension,11 studies on incidence are still few and inconsistent.
Ambient air pollution and traffic noise, especially from roads, are
correlated and suspected of being associated with the same CVD,
and therefore mutual adjustment is highly important. Most recent
studies on noise and CVD adjust for air pollution and generally the
results are found to be robust to the adjustment, suggesting that
transportation noise is indeed an independent risk factor for CVD.21
Another noise source investigated in relation to CVD risk is
occupational noise; an exposure mainly occurring during daytime.
Most existing studies are cross-sectional, and results from a few
prospective studies providing conflicting evidence, with some studies
indicating an association with CVD,22 whereas others finding no asso-
ciation,23 stressing the need for more well-designed prospective
studies.
Pathophysiology
According to the noise stress reaction model introduced by
Babisch,24non-auditory health effects of noise have been demon-
strated to activate a so-called ‘indirect pathway’, which in turn repre-
sents the cognitive perception of the sound, and its subsequent
cortical activation is related to emotional responses such as annoy-
ance and anger (reviewed in Ref. 25) This stress reaction chain can
initiate physiological stress responses, involving the hypothalamus,
the limbic system, and the autonomic nervous system with activation
2 T. Münzel et al.
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of the hypothalamus–pituitary–adrenal (HPA) axis and the sympa-
thetic–adrenal–medulla axis, and is associated with an increase in
heart rate and in levels of stress hormones (cortisol, adrenalin, and
noradrenaline) enhanced platelet reactivity, vascular inflammation,
and oxidative stress (see Figure 1). While the conscious experience
with noise might be the primary source of stress reactions during
daytime (for transportation and occupational noise), the sub-
conscious biological response during night-time in sleeping subjects,
at much lower transportation noise levels, is thought to play an im-
portant role in pathophysiology, particularly through disruption of
sleep–wake cycle, diurnal variation, and perturbation of time periods
critical for physiological and mental restoration. Recent human data
provided a molecular proof of the important pathophysiological role
of this ‘indirect pathway’ by identifying amygdalar activation (using
18F-FDGPET/CT imaging) by transportation noise in 498 subjects,
and its association with arterial inflammation and major adverse
cardiovascular events.27 These data are indeed consistent with animal
experiments demonstrating an increased release of stress hormones
(catecholamines and cortisol), higher blood pressure, endothelial
dysfunction,28 neuroinflammation, diminished neuronal nitric oxide
synthase (nNOS) expression as well as cerebral oxidative stress in
aircraft noise-exposed mice.29 These changes were substantially
more pronounced when noise exposure was applied during the sleep
phase (reflecting night-time noise exposure) and was mostly pre-
vented in mice with genetic deletion or pharmacological inhibition of
the phagocytic NADPH oxidase (NOX-2).29 These studies also
revealed substantial changes in the gene regulatory network by noise
exposure, especially within inflammatory, antioxidant defence, and
circadian clock pathways (Figure 1).28,29 The conclusions from these
experiments are supportive of a role for shortened sleep duration
and sleep fragmentation in cerebrovascular oxidative stress and
endothelial dysfunction.
Figure 1 The key mechanisms of the adverse health effects of traffic noise exposure. Environmental noise exposure causes mental stress
responses, a neuroinflammatory phenotype, and cognitive decline. This may lead to manifest psychological disorders and mental diseases or, via stress
hormone release and induction of potent vasoconstrictors, to vascular dysfunction and damage. All of these mechanisms initiate cardio-metabolic
risk factors that lead to manifest end organ damage. Of note, chronic cardio-metabolic diseases often are associated with psychological diseases and
vice versa.26 • ACTH, adrenocorticotropic hormone; ADH, antidiuretic hormone (vasopressin); ATII, angiotensin II; CRH, corticotropin-releasing
hormone; eNOS, endothelial nitric oxide synthase; ET-1, endothelin-1;NO, nitric oxide; NOX-2, phagocytic NADPH oxidase (catalytic subunit).
Current opinion reduction of environmental pollutants 3
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Likewise, we observed a significant degree of endothelial dysfunc-
tion, an increase in stress hormone release, blood pressure and a de-
crease in sleep quality in healthy subjects and patients with
established coronary artery disease, in response to night-time aircraft
noise (reviewed in Ref.25) Importantly, endothelial dysfunction was
corrected by the antioxidant vitamin C indicating increased vascular
oxidative stress in response to night-time aircraft noise exposure.
The important role of oxidative stress and inflammation for noise-
induced cardiovascular complications was also supported by changes
of the plasma proteome, centred on redox, pro-thrombotic and
proinflammatory pathways, in subjects exposed to train noise for one
night [mean SPL 54 dB(A)].30
Pathophysiology and
epidemiology of air pollution and
cardiovascular disease
Since the publication of an American Heart Association Scientific
Statement,31 there has been a consistent stream of epidemiological
and mechanistic evidence linking PM2.5, the most frequently impli-
cated air pollution component with CVD.5,6 Mounting evidence sug-
gests that health risks attributable to PM2.5 persist even at low levels,
below WHO air quality guidelines and European standards (annual
levels <10 and <25mg/m3, respectively). Updated exposure-
response dose curves suggest a robust supralinear concentration-
response-curve for PM and CVD with no apparent safe threshold
level.32
Epidemiology
Current estimates suggest air pollution is associated with around 9
million premature deaths, worldwide annually with 40–60% of
mortality attributed to cardiovascular causes.5,33Short-term expos-
ure (over hours or days) is associated with increased risk for myocar-
dial infarction, stroke, heart failure, arrhythmia, and sudden death by
about 1–2% per 10mg/m3. Longer-term exposure over months or
years, amplifies these risk associations, to 5–10% per 10mg/m3. Living
in regions with poor air quality potentiates the atherosclerotic
process and promotes the development of several chronic cardio-
metabolic conditions (e.g. diabetes, hypertension).
Although the strength of the association for criteria air pollu-
tants is strongest for PM2.5, there are data linking other pollutants
such as nitrogen oxides (e.g. NO2) and less consistently ozone
(O3) with cardiovascular events.
32 Pollutants from traffic and
combustion sources are of high concern (due to high levels of
ultrafine PM, toxicity of constituents, and penetration of pollu-
tants systemically) although precise burden estimates have yet
to be established for this source. Coarse PM10 air pollution from
anthropogenic sources has been associated with cardiovascular
disease although sources such as agricultural emissions and crustal
material are less well studied.
Given the continuing links between PM2.5 and adverse cardiovas-
cular events, even at levels substantially below 10mg/m3, there is a
need for a realistic lower limit that may strike the balance between
what is reasonably possible and eliminating anthropogenic sources. It
is important to keep in mind that complete elimination of all PM2.5
may not possible given that some PM2.5 is natural. Calculations by
Lelieveld et al.33 of a complete phase-out of fossil fuel-related
emissions (needed to achieve the 2C climate change goal under
the Paris Agreement) demonstrated a reduction in excess mortal-
ity rate of 3.61 million per year worldwide. The increase in mean
life expectancy in Europe would be around 1.2 years indicating
a tremendous health co-benefit from the phase-out of carbon
dioxide emissions.
Pathophysiology
Mechanistic studies, using controlled exposure studies in humans and
experimental models support a causal relationship between PM and
CVD. Acute exposure to air pollutants induces rapid changes that in-
clude vasoconstriction, endothelial dysfunction, arterial stiffening, ar-
rhythmia, exacerbation of cardiac ischaemia, increased blood
coagulability, and decreased fibrinolytic capacity. Additionally, long-
term exposure to PM accelerates the growth and vulnerability of ath-
erosclerotic plaques.34 A broad range of mechanisms accounts for
pathophysiology at an organ and cellular level, with inflammation and
oxidative stress playing key roles.25 Additionally, several convincing
pathways can account for the link between inhalation of pollutants
and the cardiovascular system, including passage of inflammatory
(and other) mediators into the circulation, direct passage of particles
(or their constituents) into circulation, imbalance of autonomic ner-
vous system activity, and changes to central control of endocrine sys-
tems. The contribution of individual pathways will depend on type of
pollutant, the exposure (dose and duration), specific cardiovascular
endpoints, and the health status of individual. Finally, the cardiovascu-
lar effects of pollutants occur in both healthy individuals and those
with pre-existing cardiorespiratory disease, suggesting a potential
contributory role on the induction, progression, and exacerbation of
CVD.32,34
Mitigation strategies
Noise mitigation
In 2020, the European Environment Agency concluded that more
than 20% of the EU population live with road traffic noise levels that
are harmful to health and that this proportion is likely to increase in
the future (see https://www.eea.europa.eu/publications/environmen
tal-noise-in-europe [last accessed 17/09/2020]). European
Environment Agency also estimated that in EU, 22 million live with
high railway noise and 4 million with high aircraft noise.
The authorities can use different strategies to reduce levels of traf-
fic noise (Table 1). For road traffic, the sound generated by the con-
tact between the tires and the pavement is the dominant noise
source, at speeds above 35 km/h for cars and above 60 km/h for
trucks. Therefore, changing to electric cars will result in only minor
reductions in road traffic noise. Generally applied strategies for
reducing road traffic noise include noise barriers in densely populated
areas, applying quiet road surfaces, and reducing speed, especially
during night-time. Furthermore, there is a great potential in develop-
ing and using low-noise tires. As many of these mitigation methods
result in only relatively small changes in noise (Table 1), a combination
of different methods is important in highly exposed areas. For aircraft
noise, mitigation strategies include to minimizing overlapping of air
4 T. Münzel et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa745/5952791 by guest on 06 N
ovem
ber 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.traffic routes and housing zones, introduction of night bans, and im-
plementation of continuous descent arrivals, which require the air-
craft to approach on steeper descents with lower, less variable
throttle settings. For railway noise, replacing cast-iron block breaks
with composite material, grinding of railway tracks and night bans, are
among the preferred strategies for reducing noise. Lastly, installing
sound-reducing windows and/or orientation of the bedroom to-
wards the quiet side of the residence can reduce noise exposure.
Air pollution mitigation
Although it is widely recognized that legislation, policies, regulation,
and technology, coupled with enforcement, are critical to reduction
of air pollution levels, the political momentum required to accom-
plish this globally is currently limited. Thus, personal measures to
mitigate risk take on a much greater importance. The current experi-
ence and lessons learned with personal protective equipment and
mitigation in reducing exposure to SARS-CoV2 are highly reminis-
cent of their use in combating air pollution, albeit the protection pro-
vided varies depending on the pollutant.35 Mitigation measures must
be affordable and broadly applicable to the population, and the level
of protection provided should match the risk of population that is
being exposed (Figure 2). The latter would necessitate an understand-
ing of the health risk of the patient/community and degree of expos-
ure. The need and urgency plus intensity of any recommended
intervention also need to be weighed against their potential benefits
vs. risks for each individual (e.g. wasted effort, resources, unnecessary
concern, or possible complacency of the user). Although no inter-
vention to reduce air pollution exposure has as yet been shown to
reduce cardiovascular events, the consistent link between increased
levels of PM2.5 and cardiovascular events, evidence for measures in
lowering PM2.5 levels, and the impact of several mitigation strategies
in improving surrogate markers are highly suggestive that interven-
tions could be correspondingly impactful in reducing cardiovascular
events.
Current approaches to mitigate air pollution and their impact have
been previously reviewed and can be broadly classified into: (i) Active
personal exposure mitigation with home air cleaning and personal
equipment (Table 2); (ii) Modification of human behaviour to reduce
passive exposures; (iii) Pharmacologic approaches.32 Studies on N95
respirator under ambient PM2.5 exposure conditions at both high and
low levels of exposures over a few hours have shown to reduce sys-
tolic blood pressure and improve heart rate variability.32,36 In the
only trial comparing exposure mitigation to both noise and air pollu-
tion, individual reduction of air pollution or noise with a respirator or
noise-cancelling headphones, respectively, did not alter blood pres-
sure. Heart rate variability indices were, however, variably improved
with either intervention.37 Face masks and procedural masks (e.g.
surgical masks) are widely available but are not effective in filtering
PM2.5, especially if poorly fitting or worn during high activity,
38 and
therefore cannot be recommended for widespread usage if N95 res-
pirators are available. Closing car windows, air-conditioning, and
cabin air filters represent approaches that could be important in
those who are susceptible, but only in those spending large amounts
of time in transportation microenvironments. Behavioural strategies
such as air pollution avoidance by changing travel routes, staying in-
doors/closing windows, and modification of activity can help limit air
pollution exposure, but unintended consequences in some instances
have the potential of offsetting benefit. An example is closing win-
dows to limit outdoor exposure but increasing the hazard for indoor
air pollutants or limiting outdoor recreation/exercise to mitigate am-
bient exposures. The latter scenario of limiting outdoor exposure
brings up some very practical questions about the risk/benefit of loss
of cardiovascular benefits of exercise vs. potential gain from benefits
secondary to air pollution mitigation. Health impact modelling and
epidemiologic studies have demonstrated that the benefits of aerobic
exercise nearly always exceed the risk of air pollution exposure
across a range of concentrations, and for long durations of exercise
for normal individuals (>75 min). Based on current evidence, guiding
healthy people to avoid outdoor activity in areas with high PM2.5 pol-
lution has the potential to produce greater harm than benefit, given
the low absolute risk for cardiovascular or respiratory events. On the
other hand, advising patients with pre-established CVD to continue
....................................................................................................................................................................................................................
Table 1 Mitigation methods resulting in reduction in road traffic noise
Change in noise Perceived change Methods for noise reduction
1 dB A very small change. Reduce speed by 10 km/h
Replace all cars with electric cars
Shift traffic from night-time to day-time period
Remove 25% of the traffic
3 dB An audible, but small change. Reduce speed by 30 km/h
Apply quiet road surfaces
Use low-noise emitting tires
Remove 50% of the traffic
5 dB A substantial change. Build noise barriers
Remove 65% of traffic
10 dB A large change. Sounds like a halving of the sound. Build high noise barriers
Remove 90% of the traffic
Sound-reducing windows
Current opinion reduction of environmental pollutants 5
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..to remain >400 m away from major roadways to avoid exposure to
traffic pollutants is a reasonable measure, despite the current lack of
strong evidentiary support.
Although a variety of over the counter drugs and medications have
been shown to mitigate association between air pollution and surro-
gates, almost none can be recommended to protect against air pollu-
tion mediated adverse health effects at this time. However, the use of
medications for primary and secondary prevention of CHD should
be encouraged if indicated for other reasons.
Housing and urban design to improve
cardiovascular health
Two-third of the European population live in urban areas and this
number continues to grow. A recent Statement on Air Quality Policy
has discussed aspects in the built environment that may be targeted
in order to reduce exposures to PM2.5 (in press 2020). Briefly, built
environment features may directly or indirectly modify adverse car-
diovascular effects of air pollution through the indoor living environ-
ment, green spaces, roads, utilities, and transportation infrastructure.
The design of communities has the potential of impacting exposures,
by affecting the continuum of human existence across indoor living,
commuting, working, and recreation (Figure 3). The layout of roads,
sidewalks, green spaces, and the availability of cheap public trans-
portation can affect travel behaviour and can help alleviate air qual-
ity.39 Communities with proximity and compactness have been
associated with higher life expectancy, improved air quality, and
health.40,41 Green environments can improve air quality, encour-
age physical activity, and promote social interactions, ultimately
improving cardiovascular health. Indeed, there is evidence to sup-
port a protective association of green spaces on PM-associated
CVD.42,43All-cause and ischaemic heart disease mortality related
to income deprivation has been shown to be lower in populations
who live in the greenest areas, vs. those who have less exposure to
green space.44 Recently, Giles-Corti identified eight integrated re-
gional and local interventions that, when combined, encourage
walking, cycling and public transport use, while reducing private
motor vehicle use.45 These eight interventions are directed to re-
duce traffic exposure, to reduce air pollution and noise, and to re-
duce the important public health issue loneliness and social
isolation, to improve the safety from crime, to reduce physical in-
activity and prolonged sitting, and to prevent the consumption of
unhealthy diets.45
Figure 2 Mitigation measures to reduce air pollution exposure.
6 T. Münzel et al.
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Table 2 Personal active mitigation methods to reduce air pollution exposure
Type of intervention Efficacy in reducing exposure Considerations for use Evidence in reducing surrogate
outcomes
Personal air purifying respirators (reducing solid but not gaseous air pollutants).
N95 respirators Highly effective in reducing PM2.5.
Removes >95% inhaled particles
at 0.3 mm in size
Fit and use frequency are key determi-
nants of efficacy. A valve or microventila-
tor fan may reduce humidity and
enhance comfort.
Uncomfortable to wear over long
periods
Randomized controlled clinical trials
over short durations (typically up to
48 h) with evidence for reducing
blood pressure and improving heart
rate variability indices.
Surgical and cloth
masks
Not uniformly effective in reducing
PM2.5 exposure
While few studies suggest that these may
reduce exposure, highly variable in
efficacy.
Not recommended owing to variability
in reducing exposure to particles
Portable air cleaners (PAC)
Portable devices with
high efficiency-particu-
late airfilter (HEPA)
Filters. Electrostatic
PACs additionally ion-
ize particles
Designed to clean air in a small area.
Effective in reducing indoor particles
but duration of use and volume of
room, key determinants of efficacy.
Efficacy related to clean air delivery rate
normalized by room volume, which must
be competitive with ventilation and de-
position (loss) rates.
Electrostatic PACs may result in ozone
production
Overall trend in studies suggest a bene-
fit on blood pressure and heart rate
variability
Heating ventilation and air-conditioning (HVAC)
Installed centrally in
homes with filters that
reduce exposure.
Effective in reducing concentrations as
long as filters replaced regularly.
Efficacy is variable with building and op-
erational factors (i.e. open windows)
No data currently available
Figure 3 Urban design considerations to reduce exposure to noise and air pollution.
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Future perspectives: opportunities and
challenges over the next decade
Efforts to mitigate air pollution and noise are endeavours that involve
complex economic and geopolitical considerations. Measures such as
transportation reform, shift to zero-emission fuels, urban landscape
reform, and ecologically sound lifestyle changes may help simultan-
eously alleviate air/noise pollution while accomplishing climate
change goals. However, reducing air pollution and noise may have
short-term challenges due to economic incentives that are substan-
tially misaligned with health and environmental priorities and thus
opportunities to understand the importance of these factors in
human health will sadly continue. An important avenue of investiga-
tion is convergent studies that look at the broad and collective impact
and burden of air and noise pollution as archetypal environmental
risk factors. The questions that need to be addressed are many and
include the magnitude and time course of response of co-exposure,
interactive effects of environmental factors on surrogate measures,
duration of effect/time course of reversal, impact on circadian
rhythm, and finally the effect of reversal as well as prevention and life-
style approaches that may help mitigate risk (e.g. diet, stress, and
exercise).
The rapid development of personalized technologies that
provide multiple measures of health in fine temporal detail in
conjunction with data on environmental exposure provide an un-
precedented opportunity for research and may allow an extraor-
dinary understanding of the interactions between environmental
and non-environmental risk factors over long durations.
Together with developments in next-generation sequencing
technologies, and opportunities in big data, assimilative studies of
this nature may finally provide a granular view of the environmen-
tal–genetic interactions leading to the development of CVD.
However, the extent of these advances may be tempered by the
need to manage subject burden and costs, and imprecise data on
many environmental variables. Increased awareness of the soci-
etal burden posed by environmental risk factors and acknow-
ledgement in traditional risk factor guidelines may pressurize
politicians to intensify the efforts required for effective
legislation.
The cardiovascular community has a responsibility to help promul-
gate the impact of, not only health lifestyle and diet, but also over the
outsize impact of air and noise pollution on cardiovascular health.
Individuals can apply political pressure through democratic means
Take home figure Upper left panel reproduced from Münzel et al.46 with permission.
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.
and lobbying to enact changes at regional and national levels that lead
to reductions in noise/air pollution exposure. Patient organization
can provide a strong voice in the call for action at governmental level.
Importantly, air pollution was mentioned in the published guidelines
for cardiovascular prevention, but the recommendations to reduce
pollution were completely insufficient,47 while prevention measures
with respect to traffic noise were completely lacking. Noise and air
pollution represent significant cardiovascular risk factors, it is import-
ant that these factors are included into the ESC guidelines, and
others, for myocardial infarction, arterial hypertension, and heart
failure.
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